Question 1

What does the GILUPI CellCollector® do, and how will it be used in my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial clinical trial (NCT03732339). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the results from this test influence my chemotherapy plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial clinical trial (NCT03732339). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with using the GILUPI CellCollector®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial clinical trial (NCT03732339). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the next steps if circulating tumor cells are detected?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial clinical trial (NCT03732339). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this trial compare to standard treatment options for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial clinical trial (NCT03732339). Contact the study team or your healthcare provider for specific answers.

What this study is about